Clinical Trials Browser

Phase 1 × Leflunomide × Dermatologic × Clear all

NCT01611675 2017-04-06

Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma

Phase 1 Terminated

Melanoma, Neoplasm Metastasis